These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 2802114

  • 1. Predictive value of venom-specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom.
    Müller U, Helbling A, Bischof M.
    Allergy; 1989 Aug; 44(6):412-8. PubMed ID: 2802114
    [Abstract] [Full Text] [Related]

  • 2. Antibodies to purified bee venom proteins and peptides. II. A detailed study of changes in IgE and IgG antibodies to individual bee venom antigens.
    Kemeny DM, MacKenzie-Mills M, Harries MG, Youlten LJ, Lessof MH.
    J Allergy Clin Immunol; 1983 Oct; 72(4):376-85. PubMed ID: 6619452
    [Abstract] [Full Text] [Related]

  • 3. [The key role of IgG4 subclass antibodies in the development of protection against allergic reactions to insect stings].
    Urbanek R, Dold S.
    Monatsschr Kinderheilkd; 1986 Aug; 134(8):536-40. PubMed ID: 3773921
    [Abstract] [Full Text] [Related]

  • 4. Serial studies on the functional affinity and heterogeneity of antibodies of different IgG subclasses to phospholipase A2 produced in response to bee-venom immunotherapy.
    Devey ME, Lee SR, Richards D, Kemeny DM.
    J Allergy Clin Immunol; 1989 Sep; 84(3):326-30. PubMed ID: 2778238
    [Abstract] [Full Text] [Related]

  • 5. Sub-class of IgG anti-bee venom antibody produced during bee venom immunotherapy and its relationship to long-term protection from bee stings and following termination of venom immunotherapy.
    Urbanek R, Kemeny DM, Richards D.
    Clin Allergy; 1986 Jul; 16(4):317-22. PubMed ID: 3742787
    [Abstract] [Full Text] [Related]

  • 6. Quantification of IgG and IgG4 antibodies to bee venom phospholipase A2 by competitive inhibition in ELISA.
    Rieben R, Blaser K.
    J Immunol Methods; 1989 Apr 21; 119(1):1-8. PubMed ID: 2708823
    [Abstract] [Full Text] [Related]

  • 7. [Antibody response pattern (specific IgE and IgG) of insect sting allergic patients in immunotherapy with venom preparations].
    Wüthrich B, Arrendal H, Lanner A.
    Schweiz Med Wochenschr; 1981 Nov 14; 111(46):1756-65. PubMed ID: 7313646
    [Abstract] [Full Text] [Related]

  • 8. Immunological studies on bee-keepers: specific IgG and subclass typing IgG against bee venom and bee venom components.
    Urbanek R, Forster J, Ziupa J, Karitzky D.
    Klin Wochenschr; 1980 Nov 17; 58(22):1257-60. PubMed ID: 7464005
    [Abstract] [Full Text] [Related]

  • 9. Correlation of IgG and IgE antibody levels to honey bee venom allergens with protection to sting challenge.
    Hoffman DR, Gillman SA, Cummins LH, Kozak PP, Oswald A.
    Ann Allergy; 1981 Jan 17; 46(1):17-23. PubMed ID: 6257151
    [Abstract] [Full Text] [Related]

  • 10. Antibodies to purified bee venom proteins and peptides. I. Development of a highly specific RAST for bee venom antigens and its application to bee sting allergy.
    Kemeny DM, Harries MG, Youlten LJ, Mackenzie-Mills M, Lessof MH.
    J Allergy Clin Immunol; 1983 May 17; 71(5):505-14. PubMed ID: 6601672
    [Abstract] [Full Text] [Related]

  • 11. Honeybee venom allergy: immunoblot studies in allergic patients after immunotherapy and before sting challenge.
    Jeep S, Paul M, Müller U, Kunkel G.
    Allergy; 1996 Aug 17; 51(8):540-6. PubMed ID: 8874657
    [Abstract] [Full Text] [Related]

  • 12. The prognostic significance of specific IgG antibodies in insect sting allergy.
    Urbanek R, Forster J, Karitzky D, Ziupa J.
    Eur J Pediatr; 1981 Mar 17; 136(1):31-4. PubMed ID: 7215389
    [Abstract] [Full Text] [Related]

  • 13. Hymenoptera venom allergy.
    Przybilla B, Ruëff F.
    J Dtsch Dermatol Ges; 2010 Feb 17; 8(2):114-27; quiz 128-30. PubMed ID: 19751222
    [Abstract] [Full Text] [Related]

  • 14. Clinical and immunological studies of beekeepers.
    Light WC, Reisman RE, Wypych JI, Arbesman CE.
    Clin Allergy; 1975 Dec 17; 5(4):389-95. PubMed ID: 1053439
    [Abstract] [Full Text] [Related]

  • 15. Immunotherapy in bee-sting anaphylaxis. Use of honeybee venom.
    Busse WW, Reed CE, Lichtenstein LM, Reisman RE.
    JAMA; 1975 Mar 17; 231(11):1154-6. PubMed ID: 1172815
    [Abstract] [Full Text] [Related]

  • 16. Discontinuation of bee venom immunotherapy in children and adolescents.
    Urbanek R, Forster J, Kuhn W, Ziupa J.
    J Pediatr; 1985 Sep 17; 107(3):367-71. PubMed ID: 4032132
    [Abstract] [Full Text] [Related]

  • 17. Isotypic and idiotypic characterization of anti-bee venom phospholipase A2 antibodies.
    Wetterwald A, Skvaril F, Müller U, Blaser K.
    Int Arch Allergy Appl Immunol; 1985 Sep 17; 77(1-2):195-7. PubMed ID: 4008074
    [Abstract] [Full Text] [Related]

  • 18. IgE-Api m 4 Is Useful for Identifying a Particular Phenotype of Bee Venom Allergy.
    Ruiz B, Serrano P, Moreno C.
    J Investig Allergol Clin Immunol; 2016 Sep 17; 26(6):355-361. PubMed ID: 27996941
    [Abstract] [Full Text] [Related]

  • 19. Insect-sting challenge in 324 subjects with a previous anaphylactic reaction: current criteria for insect-venom hypersensitivity do not predict the occurrence and the severity of anaphylaxis.
    van der Linden PW, Hack CE, Struyvenberg A, van der Zwan JK.
    J Allergy Clin Immunol; 1994 Aug 17; 94(2 Pt 1):151-9. PubMed ID: 8064067
    [Abstract] [Full Text] [Related]

  • 20. Changes in IgG and IgE antibody levels to bee venom during immunotherapy.
    Ferrante A, Mocatta F, Goh DH.
    Int Arch Allergy Appl Immunol; 1986 Aug 17; 81(3):284-7. PubMed ID: 3770979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.